Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal PD-L1 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | PD-L1 antibody was raised against a 17 amino acid synthetic peptide from near the center of human PD-L1. The immunogen is located within amino acids 60 - 110 of PD-L1. |
Rabbit Polyclonal Anti-Angiotensin II Receptor Type-1 (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide NSSTEDGIKRIQDDC, corresponding to amino acid residues 4-18 of human AT1 receptor. Extracellular, N-terminus. |
USD 524.00
In Stock
Rabbit Polyclonal Anti-Serotonin Transporter (SERT) (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide (C)EMRNEDVSEVAKD, corresponding to amino acids residues 388-400 of rat Serotonin Transporter. 4th extracellular loop. |
Rabbit polyclonal CP Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This CP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 547-577 amino acids from the Central region of human CP. |
Rabbit polyclonal CYP27B1 Antibody (C-term)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This CYP27B1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 482-508 amino acids from the C-terminal region of human CYP27B1. |
Rabbit Polyclonal Anti-Nectin-1 (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide (C)GKPPSVVSWETRLK, corresponding to amino acid residues 177- 190 of human nectin-1. Extracellular, N-terminus. |
Rabbit Polyclonal Anti-Cholecystokinin B Receptor (extracellular)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide CETPRIRGTGTRELE, corresponding to amino acid residues 39-53 of mouse Cholecystokinin B Receptor. Extracellular, N-terminus. |
Rabbit Polyclonal 53BP1 Antibody
| Applications | FC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The epitope recognized by this antibody maps to a region between residues 350 and 400 of human 53BP1 [NP_005648.1 (GeneID 7158)]. |
Rabbit polyclonal ENOA Antibody (N-term)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This ENOA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 33-60 amino acids from the N-terminal region of human ENOA. |
Rabbit polyclonal GC Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This GC antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 337-365 amino acids from the Central region of human GC. |
Rabbit Polyclonal CXCR4 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | CXCR4 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human CXCR4. The immunogen is located within the first 50 amino acids of CXCR4. |
Rabbit polyclonal LMO4 Antibody (Center)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This LMO4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 104-131 amino acids from the Central region of human LMO4. |
Rabbit polyclonal KLF6 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This KLF6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 159-186 amino acids from the C-terminal region of human KLF6. |
Rabbit polyclonal EMX1 Antibody (C-term)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This EMX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 228-257 amino acids from the C-terminal region of human EMX1. |
Rabbit Polyclonal Anti-alpha1D-Adrenoceptor (extracellular)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide (C)EPVPPDERF*SGITEE, corresponding to amino acid residues 231-245 of rat a1D-Adrenoceptor with replacement of cysteine 240 (C240) with serine (*S). 3rd extracellular loop. |
Rabbit Polyclonal Antibody against SOX2 - Embryonic Stem Cell Marker
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse, Sheep |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to the N-terminal region of human SOX2 protein (within residues 1-100). [Swiss-Prot# P48431] |
Rabbit Polyclonal Antibody against OPRS1 (N-term)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This OPRS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 47-81 amino acids from the N-terminal region of human OPRS1. |
Rabbit polyclonal Parkin Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This Parkin antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 387-417 amino acids from the C-terminal region of human Parkin. |
Rabbit polyclonal KLF5 Antibody (C-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This KLF5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 341-370 amino acids from the C-terminal region of human KLF5. |
Rabbit polyclonal SMAD3-S208 Antibody
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This SMAD3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 186-215 amino acids from human SMAD3. |
Rabbit polyclonal Anti-TrkA (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide (C)ETMRHG(S)LRLNQPTH, corresponding to amino acid residues 342-356 of rat TrkA . Extracellular, 2nd immunoglobulin-like domain. |
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
USD 509.00
In Stock
Rabbit polyclonal LIN28A Antibody (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | This LIN28A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 108-138 amino acids from the Central region of human LIN28A. |
Rabbit polyclonal SOS2 Antibody (N-term)
| Applications | FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SOS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 188-215 amino acids from the N-terminal region of human SOS2. |
Rabbit polyclonal WNT5B Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This WNT5B antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 153-182 amino acids from the Central region of human WNT5B. |
Rabbit polyclonal HDAC2 Antibody (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HDAC2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 410-439 amino acids from the Central region of human HDAC2. |
Rabbit polyclonal Anti-VPAC1 (extracellular)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide (C)EEAQLENETIG(S)SK, corresponding to amino acid residues 52-65 of human VPAC1 (Accession P32241). Extracellular, N-terminus. |
USD 524.00
In Stock
Active filters
Reactivities
- Mouse
Applications
- FC
Antibody Hosts
- Rabbit
Filter by
Category
Target Symbol
- BAD (3)
- CD274 (3)
- HSPD1 (3)
- SCARB1 (3)
- SMAD2 (3)
- STIP1 (3)
- AKT2 (2)
- ALDH1A1 (2)
- ALPL (2)
- CASP3 (2)
- CCR7 (2)
- CCRL2 (2)
- CD27 (2)
- CD3E (2)
- CD40 (2)
- CD74 (2)
- CD79B (2)
- CD8A (2)
- CP (2)
- CREB1 (2)
- CTNNA1 (2)
- CXCR4 (2)
- DDAH1 (2)
- DDIT3 (2)
- ENO1 (2)
- FSCN1 (2)
- GAP43 (2)
- HSP90AB1 (2)
- IL2RA (2)
- IL4 (2)
- IL9 (2)
- ILK (2)
- ITGB7 (2)
- LMO2 (2)
- LY6G (2)
- MAP1LC3A (2)
- MAP2K3 (2)
- MAPK1 (2)
- MYC (2)
- PCNA (2)
- PDCD1 (2)
- PRNP (2)
- RGS10 (2)
- SOX2 (2)
- SQSTM1 (2)
- STAG2 (2)
- TCR (2)
- TIGIT (2)
- TIMD4 (2)
- TLR7 (2)
- TNFRSF18 (2)
- TNFRSF1B (2)
- TNFSF18 (2)
- TNFSF9 (2)
- TOMM20 (2)
- UBB (2)
- YWHAB (2)
- ABCD3 (1)
- ABI1 (1)
- ACKR3 (1)
- ACLY (1)
- ACTA1 (1)
- ACTC1 (1)
- ADGRB1 (1)
- ADGRE1 (1)
- ADH1B (1)
- ADH4 (1)
- ADIPOR1 (1)
- ADRA1D (1)
- AGER (1)
- AGTR1 (1)
- AKT1 (1)
- AKT3 (1)
- ALCAM (1)
- ANKH (1)
- ANXA2 (1)
- ANXA5 (1)
- ANXA7 (1)
- ARF1 (1)
- ARPC1A (1)
- ARRB1 (1)
- ATP2A2 (1)
- ATP6V1E1 (1)
- ATP7B (1)
- BAK1 (1)
- BCL2 (1)
- BCL2L1 (1)
- BRAF (1)
- BRS3 (1)
- BSG (1)
- BTLA (1)
- BUB1B (1)
- C7 (1)
- CACNA2D3 (1)
- CALB2 (1)
- CAMK2B (1)
- CASR (1)
- CBFB (1)
- CBX3 (1)
- CBX5 (1)
Isotypes
Clonalities
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (33)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (15)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (144)
- Transmembrane (55)
- Transcription Factors (44)
- ES Cell Differentiation/IPS (28)
- Stem cell - Pluripotency (19)
- Protein Kinase (17)
- GPCR (13)
- Embryonic stem cells (11)
- Secreted Protein (10)
- Induced pluripotent stem cells (7)
- Protease (7)
- Cancer stem cells (5)
- Stem cell relevant signaling - JAK/STAT signaling pathway (5)
- Adult stem cells (4)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (4)
- Nuclear Hormone Receptor (3)
- Ion Channels: Cys-loop Receptors (2)
- Phosphatase (2)
- Stem cell relevant signaling - Wnt Signaling pathway (2)
- Ion Channels: ATP Receptors (1)
- Ion Channels: Other (1)
- Ion Channels: Potassium (1)
- P450 (1)
Pathways
- Pathways in cancer (34)
- Metabolic pathways (20)
- MAPK signaling pathway (18)
- Colorectal cancer (17)
- Chronic myeloid leukemia (15)
- ErbB signaling pathway (15)
- Prostate cancer (15)
- Acute myeloid leukemia (14)
- Focal adhesion (14)
- Neurotrophin signaling pathway (14)
- Chemokine signaling pathway (13)
- Endometrial cancer (13)
- Insulin signaling pathway (13)
- Pancreatic cancer (13)
- Toll-like receptor signaling pathway (13)
- Non-small cell lung cancer (11)
- T cell receptor signaling pathway (10)
- Wnt signaling pathway (10)
- Bladder cancer (9)
- Fc epsilon RI signaling pathway (9)
- Glioma (9)
- Melanoma (9)
- Regulation of actin cytoskeleton (9)
- Renal cell carcinoma (9)
- VEGF signaling pathway (9)
- mTOR signaling pathway (9)
- Adherens junction (8)
- Alzheimer's disease (8)
- Cell cycle (8)
- Cytokine-cytokine receptor interaction (8)
- Melanogenesis (8)
- Natural killer cell mediated cytotoxicity (8)
- Neuroactive ligand-receptor interaction (8)
- Progesterone-mediated oocyte maturation (8)
- TGF-beta signaling pathway (8)
- Adipocytokine signaling pathway (7)
- B cell receptor signaling pathway (7)
- GnRH signaling pathway (7)
- Jak-STAT signaling pathway (7)
- Thyroid cancer (7)
- Apoptosis (6)
- Axon guidance (6)
- Cell adhesion molecules (CAMs) (6)
- Endocytosis (6)
- Fc gamma R-mediated phagocytosis (6)
- NOD-like receptor signaling pathway (6)
- Prion diseases (6)
- RNA degradation (6)
- Small cell lung cancer (6)
- Vascular smooth muscle contraction (6)
- Amyotrophic lateral sclerosis (ALS) (5)
- Epithelial cell signaling in Helicobacter pylori infection (5)
- Glycolysis / Gluconeogenesis (5)
- Huntington's disease (5)
- Leukocyte transendothelial migration (5)
- Long-term depression (5)
- Long-term potentiation (5)
- Antigen processing and presentation (4)
- Arginine and proline metabolism (4)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (4)
- Calcium signaling pathway (4)
- Dorso-ventral axis formation (4)
- Gap junction (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- Oocyte meiosis (4)
- Tight junction (4)
- Type II diabetes mellitus (4)
- p53 signaling pathway (4)
- Basal cell carcinoma (3)
- Dilated cardiomyopathy (3)
- Drug metabolism - cytochrome P450 (3)
- Hedgehog signaling pathway (3)
- Hematopoietic cell lineage (3)
- Metabolism of xenobiotics by cytochrome P450 (3)
- Nucleotide excision repair (3)
- Parkinson's disease (3)
- Pathogenic Escherichia coli infection (3)
- Retinol metabolism (3)
- Type I diabetes mellitus (3)
- Tyrosine metabolism (3)
- Ubiquitin mediated proteolysis (3)
- Alanine (2)
- Base excision repair (2)
- Cardiac muscle contraction (2)
- DNA replication (2)
- ECM-receptor interaction (2)
- Fatty acid metabolism (2)
- Glutathione metabolism (2)
- Lysosome (2)
- Porphyrin and chlorophyll metabolism (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- Renin-angiotensin system (2)
- Viral myocarditis (2)
- aspartate and glutamate metabolism (2)
- ABC transporters (1)
- Allograft rejection (1)
- Asthma (1)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Complement and coagulation cascades (1)
- Cysteine and methionine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Drug metabolism - other enzymes (1)
- Folate biosynthesis (1)
- Glycosaminoglycan degradation (1)
- Heparan sulfate biosynthesis (1)
- Maturity onset diabetes of the young (1)
- Mismatch repair (1)
- Nitrogen metabolism (1)
- Notch signaling pathway (1)
- Other glycan degradation (1)
- PPAR signaling pathway (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Primary bile acid biosynthesis (1)
- Primary immunodeficiency (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of autophagy (1)
- Sphingolipid metabolism (1)
- Spliceosome (1)
- Steroid biosynthesis (1)
- Tryptophan metabolism (1)
- tyrosine and tryptophan biosynthesis (1)